Neonatal bilirubin binding capacity discerns risk of neurological dysfunction

Pediatric Research

Volumn 77, Issue 2, 2015, Pages 334-339

  Lamola, Angelo A ^a   Bhutani, Vinod K ^a   Du, Lizhong ^b   Castillo Cuadrado, Martin ^a   Chen, Lihua ^b   Shen, Zheng ^b   Wong, Ronald J ^a   Stevenson, David K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; PROTEIN BINDING;

ARTICLE; BILIRUBIN BINDING; BRAIN DYSFUNCTION; EXCHANGE BLOOD TRANSFUSION; FLUOROMETRY; GESTATIONAL AGE; HEMATOFLUOROMETRY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEUROTOXICITY; NEWBORN; PHOTOTHERAPY; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT; ANALYSIS OF VARIANCE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; METABOLISM; MULTICENTER STUDY; NEUROTOXICITY SYNDROMES; PROCEDURES; PROSPECTIVE STUDY; STATISTICAL MODEL;

ANALYSIS OF VARIANCE; BILIRUBIN; FLUOROMETRY; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LOGISTIC MODELS; NEUROTOXICITY SYNDROMES; PROSPECTIVE STUDIES; PROTEIN BINDING; RISK ASSESSMENT;

EID: 84927130138     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2014.191     Document Type: Article

References (27)

1. Ahlfors CE. Criteria for exchange transfusion in jaundiced newborns. Pediatrics 1994; 93: 488-94.
2. Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage-mechanisms and management approaches. N Engl J Med 2013; 369: 2021-30.
3. Ahlfors CE. Predicting bilirubin neurotoxicity in jaundiced newborns. Curr Opin Pediatr 2010; 22: 129-33.
4. Ahlfors CE, Wennberg RP, Ostrow JD, Tiribelli C. Unbound (free) bilirubin: improving the paradigm for evaluating neonatal jaundice. Clin Chem 2009; 55: 1288-99.
5. Gamaleldin R, Iskander I, Seoud I, et al. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics 2011; 128: e925-31.
6. American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
7. Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol 2012; 32: 660-4.
8. Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006; 117: 474-85.
9. Bender GJ, Cashore WJ, Oh W. Ontogeny of bilirubin-binding capacity and the effect of clinical status in premature infants born at less than 1300 grams. Pediatrics 2007; 120: 1067-73.
10. Cashore WJ, Horwich A, Karotkin EH, Oh W. Influence of gestational age and clinical status on bilirubin-binding capacity in newborn infants. Sephadex G-25 gel filtration technique Am J Dis Child 1977; 131: 898-901.
11. Odell GB. Influence of binding on the toxicity of bilirubin Ann NY Acad Sci 1973; 226: 225-37.
12. Harris RC, Lucey JF, Maclean JR. Kernicterus in premature infants associated with low concentrations of bilirubin in the plasma. Pediatrics 1958; 21: 875-84.
13. Wells R, Hammond K, Lamola AA, Blumberg WE. Relationships of bilirubin binding parameters. Clin Chem 1982; 28: 432-9.
14. Amin SB, Lamola AA. Newborn jaundice technologies: unbound bilirubin and bilirubin binding capacity in neonates. Semin Perinatol 2011; 35: 134-40.
15. Brown AK, Eisinger J, Blumberg WE, Flores J, Boyle G, Lamola AA A rapid fluorometric method for determining bilirubin levels and binding in the blood of neonates: comparisons with a diazo method and with 2-(4'-hydroxybenzene)azobenzoic acid dye binding. Pediatrics 1980; 65: 767-76.
16. Cashore WJ, Oh W, Blumberg WE, Eisinger J, Lamola AA. Rapid fluorometric assay of bilirubin and bilirubin binding capacity in blood of jaundiced neonates: comparisons with other methods. Pediatrics 1980; 66: 411-6.
17. Lamola AA, Eisinger J, Blumberg WE, Patel SC, Flores J. Flurorometric study of the partition of bilirubin among blood components: basis for rapid microassays of bilirubin and bilirubin binding capacity in whole blood Anal Biochem 1979; 100: 25-42.
18. Lamola AA, Fanaroff AA. Bilirubin fluorescence and prevention of kernicterus. Diagn Med 1984; 7: 9-12.
19. Ahlfors CE. Unbound bilirubin associated with kernicterus: a historical approach. J Pediatr 2000; 137: 540-4.
20. Ahlfors CE, Amin SB, Parker AE. Unbound bilirubin predicts abnormal automated auditory brainstem response in a diverse newborn population. J Perinatol 2009; 29: 305-9.
21. Amin SB, Ahlfors C, Orlando MS, Dalzell LE, Merle KS, Guillet R. Bilirubin and serial auditory brainstem responses in premature infants. Pediatrics 2001; 107: 664-70.
22. Funato M, Tamai H, Shimada S, Nakamura H. Vigintiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics 1994; 93: 50-3.
23. Nakamura H, Takada S, Shimabuku R, Matsuo M, Matsuo T, Negishi H Auditory nerve and brainstem responses in newborn infants with hyperbilirubinemia. Pediatrics 1985; 75: 703-8.
24. McDonagh AF, Maisels MJ. Bilirubin unbound: deja vu all over again?. Pediatrics 2006; 117: 523-5.
25. Doumas BT, Watson WA, Biggs HG Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 1971; 31: 87-96.
26. Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low-birthweight infants. Pediatrics 1982; 69: 481-5.
27. Ritter DA, Kenny JD, Norton HJ, Rudolph AJ A prospective study of free bilirubin and other risk factors in the development of kernicterus in premature infants. Pediatrics 1982; 69: 260-6.